Invasive Group B Streptococcus Disease With Recurrence and in Multiples: Towards a Better Understanding of GBS Late-Onset Sepsis.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2021
Historique:
received: 15 10 2020
accepted: 04 05 2021
entrez: 21 6 2021
pubmed: 22 6 2021
medline: 24 8 2021
Statut: epublish

Résumé

Group B Streptococcus (GBS) is a common intestinal colonizer during the neonatal period, but also may cause late-onset sepsis or meningitis in up to 0.5% of otherwise healthy colonized infants after day 3 of life. Transmission routes and risk factors of this late-onset form of invasive GBS disease (iGBS) are not fully understood. Cases of iGBS with recurrence (n=25) and those occurring in parallel in twins/triplets (n=32) from the UK and Ireland (national surveillance study 2014/15) and from Germany and Switzerland (retrospective case collection) were analyzed to unravel shared (in affected multiples) or fixed (in recurrent disease) risk factors for GBS disease. The risk of iGBS among infants from multiple births was high (17%), if one infant had already developed GBS disease. The interval of onset of iGBS between siblings was 4.5 days and in recurrent cases 12.5 days. Disturbances of the individual microbiome, including persistence of infectious foci are suggested e.g. by high usage of perinatal antibiotics in mothers of affected multiples, and by the association of an increased risk of recurrence with a short term of antibiotics [aOR 4.2 (1.3-14.2), P=0.02]. Identical GBS serotypes in both recurrent infections and concurrently infected multiples might indicate a failed microbiome integration of GBS strains that are generally regarded as commensals in healthy infants. The dynamics of recurrent GBS infections or concurrent infections in multiples suggest individual patterns of exposure and fluctuations in host immunity, causing failure of natural niche occupation.

Identifiants

pubmed: 34149682
doi: 10.3389/fimmu.2021.617925
pmc: PMC8208644
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

617925

Informations de copyright

Copyright © 2021 Freudenhammer, Karampatsas, Le Doare, Lander, Armann, Acero Moreno, Boyle, Buxmann, Campbell, Chalker, Cunney, Doherty, Davies, Efstratiou, Elling, Endmann, Essers, Hentschel, Jones, Kallsen, Kapatai, Krüger, Ladhani, Lamagni, Lindsay, Meehan, O’Sullivan, Patel, Reynolds, Roll, Schulzke, Smith, Stein, von der Wense, Voss, Wieg, Härtel, Heath and Henneke.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Infection. 2017 Aug;45(4):449-458
pubmed: 28236250
Arch Pediatr. 2017 Dec;24 Suppl 3:S24-S28
pubmed: 29433694
Nat Med. 2014 May;20(5):524-30
pubmed: 24747744
Arch Dis Child. 2019 Apr;104(4):401-405
pubmed: 30413494
Nat Commun. 2014 Aug 04;5:4544
pubmed: 25088811
Pediatrics. 2018 Nov;142(5):
pubmed: 30309887
Scand J Immunol. 2013 Nov;78(5):426-38
pubmed: 23809143
Lancet Infect Dis. 2019 Jan;19(1):83-90
pubmed: 30497953
Arch Dis Child Fetal Neonatal Ed. 2014 Jan;99(1):F41-7
pubmed: 23955469
J Appl Microbiol. 2015 Apr;118(4):1034-47
pubmed: 25786121
J Infect. 2017 Jun;74 Suppl 1:S34-S40
pubmed: 28646960
Pediatr Infect Dis J. 1991 Aug;10(8):621-3
pubmed: 1891294
Clin Infect Dis. 2017 Nov 6;65(suppl_2):S200-S219
pubmed: 29117332
Clin Dev Immunol. 2012;2012:985646
pubmed: 22235228
Appl Microbiol Biotechnol. 2014 Jul;98(13):6051-60
pubmed: 24687755
Pediatrics. 2019 Aug;144(2):
pubmed: 31285392
Pediatr Infect Dis J. 2014 Apr;33(4):428
pubmed: 24632666
Nature. 2017 Aug 24;548(7668):407-412
pubmed: 28813414
Sci Rep. 2019 Jul 23;9(1):10635
pubmed: 31337807
Clin Infect Dis. 2019 Oct 30;69(10):1740-1748
pubmed: 30946447
J Infect Dis. 2003 Jul 15;188(2):267-71
pubmed: 12854082
Clin Infect Dis. 2009 Nov 1;49(9):1393-6
pubmed: 19814626
Lancet Infect Dis. 2014 Nov;14(11):1083-1089
pubmed: 25444407
Infect Dis Rep. 2018 Dec 05;10(3):7744
pubmed: 30662690
J Pediatr. 2013 Oct;163(4):1099-104.e1
pubmed: 23866714
Front Immunol. 2017 Nov 10;8:1497
pubmed: 29209311
Sci Rep. 2017 Nov 28;7(1):16527
pubmed: 29184093
Obstet Gynaecol. 2018 Jan;20(1):57-63
pubmed: 30008614
Clin Infect Dis. 2017 Nov 6;65(suppl_2):S160-S172
pubmed: 29117326
Pediatrics. 2014 May;133(5):e1388-91
pubmed: 24709927
Clin Infect Dis. 2017 Nov 6;65(suppl_2):S190-S199
pubmed: 29117331
Front Immunol. 2018 Feb 28;9:361
pubmed: 29599768
J Pediatr. 2013 Jun;162(6):1120-4, 1124.e1
pubmed: 23324523
Clin Infect Dis. 2014 May;58(9):1211-8
pubmed: 24647013
Clin Microbiol Infect. 2011 Sep;17(9):1294-303
pubmed: 21672083
Clin Infect Dis. 2017 Nov 6;65(suppl_2):S143-S151
pubmed: 29117324
JAMA Pediatr. 2019 Mar 1;173(3):224-233
pubmed: 30640366
Pediatrics. 1999 Jun;103(6):e77
pubmed: 10353974

Auteurs

Mirjam Freudenhammer (M)

Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Center for Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
IMM-PACT Clinician Scientist Programme, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Konstantinos Karampatsas (K)

Paediatric Infectious Diseases Research Group, Institute of Infection and Immunity, St. George's, University of London, London, United Kingdom.

Kirsty Le Doare (K)

Paediatric Infectious Diseases Research Group, Institute of Infection and Immunity, St. George's, University of London, London, United Kingdom.

Fabian Lander (F)

Department of Pediatrics, University Hospital and Medical Faculty Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.

Jakob Armann (J)

Department of Pediatrics, University Hospital and Medical Faculty Carl Gustav Carus, Technische Universität (TU) Dresden, Dresden, Germany.

Daniel Acero Moreno (D)

Department of Neonatology, Kinderkrankenhaus Amsterdamer Straße, Cologne, Germany.

Margaret Boyle (M)

Department of Health Northern Ireland, Belfast, United Kingdom.

Horst Buxmann (H)

Department of Pediatric and Adolescent Medicine, Division for Neonatology at the University Hospital Frankfurt, Frankfurt/Main, Germany.

Ruth Campbell (R)

Public Health Agency Northern Ireland, Belfast, United Kingdom.

Victoria Chalker (V)

Immunisation, Hepatitis and Blood Safety Department, Public Health England, London, United Kingdom.

Robert Cunney (R)

Health Service Executive, Health Protection Surveillance Centre, Dublin, Ireland.
Irish Meningitis and Sepsis Reference Laboratory, Temple Street Children's University Hospital, Dublin, Ireland.

Lorraine Doherty (L)

Public Health Agency Northern Ireland, Belfast, United Kingdom.

Eleri Davies (E)

Public Health Wales, Cardiff, United Kingdom.

Androulla Efstratiou (A)

National Infection Service, Public Health England, London, United Kingdom.

Roland Elling (R)

Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Center for Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Matthias Endmann (M)

Department of Pediatric and Adolescent Medicine, St. Franziskus Hospital Ahlen, Ahlen, Germany.

Jochen Essers (J)

Department of Pediatrics, University of Ulm, Ulm, Germany.

Roland Hentschel (R)

Center for Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Christine E Jones (CE)

Faculty of Medicine and Institute for Life Sciences, University of Southampton and NIHR Southampton Clinical Research Facility and NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.

Steffen Kallsen (S)

Department of Paediatrics and Youth Medicine, Klinikum Friedrichshafen, Friedrichshafen, Germany.

Georgia Kapatai (G)

Immunisation, Hepatitis and Blood Safety Department, Public Health England, London, United Kingdom.

Marcus Krüger (M)

Department of Neonatology, München Klinik Harlaching and Schwabing, Munich, Germany.

Shamez Ladhani (S)

Paediatric Infectious Diseases Research Group, Institute of Infection and Immunity, St. George's, University of London, London, United Kingdom.
Immunisation and Countermeasures Division, Public Health England, London, United Kingdom.

Theresa Lamagni (T)

National Infection Service, Public Health England, London, United Kingdom.

Diane Lindsay (D)

Scottish Microbiology Reference Laboratory, Glasgow Royal Infirmary, Glasgow, United Kingdom.

Mary Meehan (M)

Irish Meningitis and Sepsis Reference Laboratory, Temple Street Children's University Hospital, Dublin, Ireland.

Catherine P O'Sullivan (CP)

Paediatric Infectious Diseases Research Group, Institute of Infection and Immunity, St. George's, University of London, London, United Kingdom.

Darshana Patel (D)

Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Paediatric Infectious Diseases Research Group, Institute of Infection and Immunity, St. George's, University of London, London, United Kingdom.

Arlene J Reynolds (AJ)

Health Protection Scotland, Glasgow, United Kingdom.

Claudia Roll (C)

Department of Neonatology, Vest Children's Hospital Datteln, University Witten-Herdecke, Witten-Herdecke, Germany.

Sven Schulzke (S)

Department of Neonatology, University Children's Hospital Basel UKBB, Basel, Switzerland.

Andrew Smith (A)

Scottish Microbiology Reference Laboratory, Glasgow Royal Infirmary, Glasgow, United Kingdom.
Glasgow Dental Hospital and School, University of Glasgow, Glasgow, United Kingdom.

Anja Stein (A)

Department of Pediatrics, University Hospital Essen, University Duisburg-Essen, Essen, Germany.

Axel von der Wense (A)

Neonatology and Pediatric Intensive Care, Altonaer Children's Hospital, Altonaer Kinderkrankenhaus, Hamburg, Germany.

Egbert Voss (E)

Klinik Hallerwiese-Cnopfsche Kinderklinik, Nürnberg, Germany.

Christian Wieg (C)

Department of Neonatology, Klinikum Aschaffenburg, Aschaffenburg, Germany.

Christoph Härtel (C)

Department of Pediatrics, University of Würzburg, Würzburg, Germany.
PRIMAL (Priming Immunity at the Beginning of Life) Consortium, Freiburg/Lübeck, Germany.

Paul T Heath (PT)

Paediatric Infectious Diseases Research Group, Institute of Infection and Immunity, St. George's, University of London, London, United Kingdom.

Philipp Henneke (P)

Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Center for Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
PRIMAL (Priming Immunity at the Beginning of Life) Consortium, Freiburg/Lübeck, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH